Infections after hysterectomy - a placebo controlled study comparing the profylactic use of azithromycin and cefuroxime with single cefuroxime

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-517508-12-00

Enrollment

2278

Registered

2024-10-24

Start date

2024-10-24

Completion date

Unknown

Last updated

2026-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Undergoing hysterectomy

Brief summary

Deep wound and pelvic organ infections up to 30 days postoperatively

Detailed description

Surficial infections and other infections, such has urine tract infections, and fever over 38 ℃ over 2 days.

Interventions

DRUGAZITHROMYCIN

DRUGPlacebo 9mm tablet

DRUGproduct number 9905609 (Consists of Cellulos.microcrist. (Emcocel 90M); Magn.stear.). Manufactured by HUS Apteekki.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Secondary

Measure	Time frame
Surficial infections and other infections, such has urine tract infections, and fever over 38 ℃ over 2 days.	—

Primary

Measure	Time frame
Deep wound and pelvic organ infections up to 30 days postoperatively	—

Countries

Finland

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026